Peripheral naïve CD8(+) T cells as a predictive biomarker of response to lenvatinib plus an anti‐PD‐1 antibody in advanced hepatocellular carcinoma: a biomarker study

por Huang, Cheng, Xu, Bin, Zhu, Xiao‐Dong, Shen, Ying‐Hao, Li, Mei‐Ling, Zhu, Jin‐Jin, Zhou, Jian, Fan, Jia, Sun, Hui‐Chuan
Publicado 2022

Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antib...

por Xu, Bin, Zhu, Xiao-Dong, Shen, Ying-Hao, Zhu, Jin-Jin, Liu, Jie, Li, Mei-Ling, Tang, Pei-Wen, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan, Huang, Cheng
Publicado 2022

Treatment With Liraglutide Exerts Neuroprotection After Hypoxic–Ischemic Brain Injury in Neonatal Rats via the PI3K/AKT/GSK3β Pathway

por Zeng, Shan-shan, Bai, Jun-jie, Jiang, Huai, Zhu, Jin-jin, Fu, Chang-chang, He, Min-zhi, Zhu, Jiang-hu, Chen, Shang-qin, Li, Pei-jun, Fu, Xiao-qin, Lin, Zhen-lang
Publicado 2020

Neferine Protects against Hypoxic-Ischemic Brain Damage in Neonatal Rats by Suppressing NLRP3-Mediated Inflammasome Activation

por Zhu, Jin-jin, Yu, Bin-yuan, Huang, Xiao-kai, He, Min-zhi, Chen, Bin-wen, Chen, Ting-ting, Fang, Huang-yi, Chen, Shang-qin, Fu, Xiao-qin, Li, Pei-jun, Lin, Zhen-lang, Zhu, Jiang-hu
Publicado 2021

Hepatectomy After Conversion Therapy Using Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy for Patients with Unresectable Hepatocellular Carcinoma

por Zhu, Xiao-Dong, Huang, Cheng, Shen, Ying-Hao, Xu, Bin, Ge, Ning-Ling, Ji, Yuan, Qu, Xu-Dong, Chen, Lingli, Chen, Yi, Li, Mei-Ling, Zhu, Jin-Jin, Tang, Zhao-You, Zhou, Jian, Fan, Jia, Sun, Hui-Chuan
Publicado 2022